These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17671674)

  • 21. HER3 expression in cutaneous tumors.
    Wimmer E; Kraehn-Senftleben G; Issing WJ
    Anticancer Res; 2008; 28(2A):973-9. PubMed ID: 18507044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue.
    Ekberg T; Nestor M; Engström M; Nordgren H; Wester K; Carlsson J; Anniko M
    Int J Oncol; 2005 May; 26(5):1177-85. PubMed ID: 15809707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
    Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
    Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER2 gene status in primary breast cancers and matched distant metastases.
    Tapia C; Savic S; Wagner U; Schönegg R; Novotny H; Grilli B; Herzog M; Barascud AD; Zlobec I; Cathomas G; Terracciano L; Feichter G; Bubendorf L
    Breast Cancer Res; 2007; 9(3):R31. PubMed ID: 17511881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genomic changes in primary lesion and lymph node metastases of esophageal squamous cell carcinoma].
    Qin YR; Wang LD; Dora K; Guan XY; Zhuang ZH; Fan ZM; Deng W; Cao SH
    Ai Zheng; 2005 Sep; 24(9):1048-53. PubMed ID: 16159423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
    Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
    Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver.
    Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
    Acta Oncol; 2015 Apr; 54(4):480-6. PubMed ID: 25601452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
    Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review.
    Carlsson J; Nordgren H; Sjöström J; Wester K; Villman K; Bengtsson NO; Ostenstad B; Lundqvist H; Blomqvist C
    Br J Cancer; 2004 Jun; 90(12):2344-8. PubMed ID: 15150568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.
    Shen L; Shui Y; Wang X; Sheng L; Yang Z; Xue D; Wei Q
    BMC Cancer; 2008 Aug; 8():232. PubMed ID: 18700025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
    Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of immune-based therapy with cytotoxic T lymphocyte and molecular targeting therapy for HER2 in esophageal squamous cell carcinoma].
    Mimura K; Izawa S; Siba S; Maruyama T; Watanabe M; Kawaguchi Y; Fuji H; Kono K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):1918-20. PubMed ID: 22202238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR.
    Berg D; Wolff C; Malinowsky K; Tran K; Walch A; Bronger H; Schuster T; Höfler H; Becker KF
    J Cell Physiol; 2012 Jan; 227(1):204-12. PubMed ID: 21391216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.
    Komatsu S; Imoto I; Tsuda H; Kozaki KI; Muramatsu T; Shimada Y; Aiko S; Yoshizumi Y; Ichikawa D; Otsuji E; Inazawa J
    Carcinogenesis; 2009 Jul; 30(7):1139-46. PubMed ID: 19423649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
    Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
    Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.